Unlock this StockReport nowClick to Unlock

Taysha Gene Therapies Inc Cash Flow Statement

TSHA $19.92 0.6  3.2%
29/10/20
StockRank


To unlock Taysha Gene Therapies Inc's cashflow statement please upgrade your membership.

2019
Period End: 2019-12-31
Period Length: 12M
Currency: USD
Net Income/Starting Line
Non-Cash Items
Purchased R&D
Changes in Working Capital
Accrued Expenses
Cash from Operating Activities
Net Change in Cash
Starting Cash Balance
Ending Cash Balance


SIGNUP NOW LEARN MORE
Unlock Stockopedia Premium for free!
See what it can do for your stockpicking and portfolio at no expense.
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis